Cystoid Macular Edema
35
2
2
16
Key Insights
Highlights
Success Rate
73% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
17.1%
6 terminated out of 35 trials
72.7%
-13.8% vs benchmark
29%
10 trials in Phase 3/4
31%
5 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (35)
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
Effect of Video Viewing on Intravitreal Injection Experience
Cool vs Room-temperature Artificial Tears
Effectiveness of Periocular Drug Injection in CATaract Surgery
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
Minocycline Treatment for Cystoid Macular Edema
Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment
Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
Variable Interval Versus Set Interval Aflibercept for DME
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection